Research Article
Baicalin Inhibits EMT through PDK1/AKT Signaling in Human Nonsmall Cell Lung Cancer
Figure 4
Baicalin inhibited the PDK1/AKT signaling pathway in NSCLC. (a–c) Immunofluorescence staining for p-PDK1 and p-AKT after treating with baicalin. (d) Protein expression levels of p-PDK1 and p-AKT after treating with baicalin. (e, f) The p-PDK1 and p-AKT expression levels in tumor tissues of subcutaneously transplanted tumor mice.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |